Publications for Stephen Clarke

Скачать 89.95 Kb.
НазваниеPublications for Stephen Clarke
Размер89.95 Kb.
  1   2   3

Publications for Stephen Clarke

Publications for Stephen Clarke


Clarke, S., McLachlan, A. (2012), Interaction Between Complementary and Alternative Medicines and Conventional Medicines. In: Perspectives on Complementary and Alternative Medicine. (pp.227-261).United Kingdom: Imperial College Press.

Chua, W., Clarke, S., Charles, K. (2012), Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer. Supportive Care in Cancer. 20(8), 1869-1874.

Tsoli, M., Moore, M., Burg, D., Painter, A., Taylor, R., Lockie, S., Turner, N., Warren, A., Cooney, G., Oldfield, B., Clarke, S., Robertson, G. (2012), Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. Cancer Research. 72(17), 4372-4382.

Oh, B., Butow, P., Mullan, B., Hale, A., Lee, M., Guo, X., Clarke, S. (2012), A Critical Review of the Effects of Medical Qigong on Quality of Life, Immune Function, and Survival in Cancer Patients. Integrative Cancer Therapies. 11(2), 101-110.

Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Lee, M., Rosenthal, D., Larkey, L., Vardy, J. (2012), Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial. Supportive Care in Cancer. 20(6), 1235-1242.

Clarey, J., Kao, S., Clarke, S., Vardy, J. (2012), The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials. Annals of Oncology. 23(5), 1229-1233.

Hasovits, C., Clarke, S. (2012), Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics. Clinical Pharmacokinetics. 51(4), 203-224.

Chua, W., Horvath, L., Beale, P., Clarke, S. (2012), Reporting clinical trial information: colorectal cancer trials at Sydney Cancer Centre. Internal Medicine Journal. 42(4), 416-421.

Kao, S., Harvie, R., Paturi, F., Taylor, R., Davey, R., Abraham, R., Clarke, S., Marx, G., Cullen, M., Kerestes, Z., Pavlakis, N. (2012), The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin/gemcitabine. Lung Cancer. 75(2), 248-254.

Shum, A., Mahendradatta, T., Taylor, R., Painter, A., Moore, M., Tsoli, M., Tan, T., Clarke, S., Robertson, G., Polly, P. (2012), Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting. Aging. 4(2), 133-143.

Michael, M., Cullinane, C., Hatzimihalis, A., O'Kane, C., Milner, A., Booth, R., Schlicht, S., Clarke, S., Francis, P. (2012), Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance test. Cancer chemotherapy and pharmacology. 69(1), 125-35.

Jankova, L., Robertson, G., Chan, C., Tan, K., Kohonen-Corish, M., Fung, C., Clarke, C., Lin, B., Molloy, M., Chapuis, P., Bokey, L., Dent, O., Clarke, S. (2012), Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study. BMC Cancer. 12, 196.


Tan, K., Jankova, L., Chan, C., Fung, C., Clarke, C., Lin, B., Robertson, G., Molloy, M., Chapuis, P., Bokey, L., Dent, O., Clarke, S. (2011), Clinicopathological correlates and prognostic significance of glutathione S-transferase Pi expression in 468 patients after potentially curative resection of node-positive colonic cancer. Histopathology. 59(6), 1057-1070.

Mitchell, P., Broad, A., Rosenthal, M., Galettis, P., Abraham, R., Burns, I., Clarke, S., Milner, A., Diiulio, J., Links, M. (2011), Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer. Asia Pacific Journal of Clinical Oncology. 7(4), 376-384.

Jankova, L., Chan, C., Fung, C., Song, X., Kwun, S., Cowley, M., Kaplan, W., Dent, O., Bokey, E., Chapuis, P., Baker, M., Robertson, G., Clarke, S., Molloy, M. (2011), Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry. Molecular bioSystems. 7(11), 2997-3005.

Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011), Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology. 6(11), 1923-1929.

Phan, V., Tan, C., Rittau, A., Xu, H., McLachlan, A., Clarke, S. (2011), An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs. Expert opinion on drug metabolism & toxicology. 7(11), 1395-410.

Clarke, S., Chua, W., Moore, M., Kao, S., Phan, V., Tan, C., Charles, K., McMillan, D. (2011), Use of inflammatory markers to guide cancer treatment. Clinical Pharmacology and Therapeutics. 90(3), 475-478.

Chua, W., Kho, P., Moore, M., Charles, K., Clarke, S. (2011), Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer. Critical reviews in oncology/hematology. 79(3), 224-50.

Lee, A., Chick, J., Kolarich, D., Haynes, P., Robertson, G., Tsoli, M., Jankova, L., Clarke, S., Packer, N., Baker, M. (2011), Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumour. Molecular & cellular proteomics : MCP. 10(9), M900538MCP200.

Clarke, S., Yip, S., Brown, C., van Hazel, G., Ransom, D., Goldstein, D., Jeffrey, G., Tebbut, N., Buck, M., Lowenthal, R., Boland, A., Gebski, V., Zalcberg, J., Simes, R. (2011), Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis. European journal of cancer (Oxford, England : 1990). 47(12), 1826-36.

Cassidy, J., Clarke, S., Díaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Rittweger, K., Gilberg, F., Saltz, L. (2011), XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. British Journal of Cancer. 105(1), 58-64.

Kao, S., Griggs, K., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Burn, J., McCaughan, B., Henderson, D., Klebe, S. (2011), Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology. 43(4), 313-7.

Patel, D., Sharpe, L., Thewes, B., Bell, M., Clarke, S. (2011), Using the distress thermometer and hospital anxiety and depression scale to screen for psychosocial morbidity in patients diagnosed with colorectal cancer. Journal of affective disorders. 131(1-3), 412-6.

Leighl, N., Shepherd, H., Butow, P., Clarke, S., McJannett, M., Beale, P., Wilcken, N., Moore, M., Chen, E., Goldstein, D., Horvath, L., Knox, J., Krzyzanowska, M., Oza, A., Feld, R., Hedley, D., Xu, W., Tattersall, M. (2011), Supporting Treatment Decision Making in Advanced Cancer: A Randomized Trial of a Decision Aid for Patients With Advanced Colorectal Cancer Considering Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(15), 2077-84.

Kacevska, M., Downes, M., Sharma, R., Evans, R., Clarke, S., Liddle, C., Robertson, G. (2011), Extrahepatic Cancer Suppresses Nuclear Receptor-Regulated Drug Metabolism. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(10), 3170-80.

Backshall, A., Sharma, R., Clarke, S., Keun, H. (2011), Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(9), 3019-28.

Sharpe, L., Patel, D., Clarke, S. (2011), The relationship between body image disturbance and distress in colorectal cancer patients with and without stomas. Journal of Psychosomatic Research. 70(5), 395-402.

Chua, W., Charles, K., Baracos, V., Clarke, S. (2011), Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. British Journal of Cancer. 104(8), 1288-1295.

Kao, S., Yan, T., Lee, K., Burn, J., Henderson, D., Klebe, S., Kennedy, C., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011), Accuracy of Diagnostic Biopsy for the Histological Subtype of Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 6(3), 602-605.

Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., Klebe, S. (2011), Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology. 43(2), 128-132.

Zhou, J., Belov, L., Solomon, M., Chan, C., Clarke, S., Christopherson, R. (2011), Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing. Journal of Visualized Experiments. 0(55), 3322.

He, X., Clarke, S., McLachlan, A. (2011), Clinical pharmacology of chemotherapy agents in older people with cancer. Current Gerontology and Geriatrics Research. 2011, 628670.

Fung, D., Lo, A., Jankova, L., Clarke, S., Molloy, M., Robertson, G., Wilkins, M. (2011), Classification of Cancer Patients Using Pathway Analysis and Network Clustering. In: Methods in Molecular Biology: Network Biology Methods and Applications. (pp.311-336).United States: Springer.

Clarke, S., McLachlan, A. (2011), Interaction between complementary and alternative medicine with conventional anti-cancer medicine. Cancer Forum. 35:1, 18-23.


Kao, S., Pavlakis, N., Harvie, R., Vardy, J., Boyer, M., van Zandwijk, N., Clarke, S. (2010), High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clinical Cancer Research. 16(23), 5805-5813.

Oh, B., Butow, P., Mullan, B., Beale, P., Pavlakis, N., Rosenthal, D., Clarke, S. (2010), The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia-Pacific journal of clinical oncology. 6(4), 342-349.

Kao, S., Reid, G., Lee, K., Vardy, J., Clarke, S., van Zandwijk, N. (2010), Malignant Mesothelioma. Internal Medicine Journal. 40(11), 742-750.

Blinman, P., Duric, V., Nowak, A., Beale, P., Clarke, S., Briscoe, K., Boyce, A., Goldstein, D., Hudson, M., Stockler, M. (2010), Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?. European journal of cancer (Oxford, England : 1990). 46(10), 1800-7.

Chan, C., Jankova, L., Fung, C., Clarke, C., Robertson, G., Chapuis, P., Bokey, L., Lin, B., Dent, O., Clarke, S. (2010), Fascin Expression Predicts Survival After Potentially Curative Resection of Node-positive Colon Cancer. The American journal of surgical pathology. 34(5), 656-66.

Matic, M., Corradin, A., Tsoli, M., Clarke, S., Polly, P., Robertson, G. (2010), The alternatively spliced murine pregnane X receptor isoform, mPXR(Delta171-211) exhibits a repressive action. The International Journal of Biochemistry & Cell Biology. 42(5), 672-682.

Chua, W., Clarke, S. (2010), Clinical trial information as a measure of quality cancer care. Journal of Oncology Practice. 6(3), 170-171.

Zhou, J., Belov, L., Huang, P., Shin, J., Solomon, M., Chapuis, P., Bokey, L., Chan, C., Clarke, C., Clarke, S., Christopherson, R. (2010), Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing. Journal of Immunological Methods. 355(1-2), 40-51.

Moore, M., Chua, W., Charles, K., Clarke, S. (2010), Inflammation and cancer: causes and consequences. Clinical Pharmacology and Therapeutics. 87(4), 504-508.

Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Kothe, E., Lam, L., Rosenthal, D. (2010), Impact of Medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 21(3), 608-14.

Fung, C., Chan, C., Jankova, L., Dent, O., Robertson, G., Molloy, M., Bokey, L., Chapuis, P., Lin, B., Clarke, S. (2010), Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node-positive colonic cancer. Histopathology. 56(3), 319-330.

Kao, S., Phan, V., Clarke, S. (2010), Predictive Markers for Haematological Toxicity of Pemetrexed. Current drug targets. 11(1), 48-57.

Kho, P., Chua, W., Moore, M., Clarke, S. (2010), Is it prime time for personalized medicine in cancer treatment?. Personalized Medicine. 7(4), 387-397.

Kao, S., Butow, P., Bray, V., Clarke, S., Vardy, J. (2010), Patient and oncologist estimates of survival in advanced cancer patients. Psycho-Oncology. 0, 0.

Lam, F., Jankova, L., Dent, O., Molloy, M., Kwun, S., Clarke, C., Chapuis, P., Robertson, G., Beale, P., Clarke, S., Bokey, L., Chan, C. (2010), Identification of distinctive protein expression patterns in colorectal adenoma. PROTEOMICS - Clinical Applications. 4(1), 60-70.

Clarke, S., McLachlan, A., Brown, D., Cabonara, S., Kissane, R. (2010), Beyond Conventional Cancer Treatments: The Use of Complementary Therapies During Cancer Treatment: Implications for Clinicians. In: When Cancer Crosses Disciplines: A Physician's Handbook. (pp.285-315).London, UK: Imperial College Press.

Oh, B., Butow, P., Mullan, B., Clarke, S., Tattersall, M., Boyer, M., Beale, P., Vardy, J., Pavlakis, N., Larke, L. (2010), Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer. Journal of the Society for Integrative Oncology. 8(2), 56-64.


Chua, W., Moore, M., Charles, K., Clarke, S. (2009), Predictive biomarkers of clinical response to targeted antibodies in colorectal cancer. Current Opinion in Molecular Therapeutics. 11(6), 611-622.

Chapuis, P., Bokey, E., Clarke, S., Beale, P., Dent, O. (2009), Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting. ANZ Journal of Surgery. 79(10), 685-692.

Chua, W., Goldstein, D., Lee, C., Dhillon, H., Michael, M., Mitchell, P., Clarke, S., Iacopetta, B. (2009), Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer. British Journal of Cancer. 101(6), 998-1004.

Phan, V., Moore, M., McLachlan, A., Piquette-Miller, M., Xu, H., Clarke, S. (2009), Ethnic differences in drug metabolism and toxicity from chemotherapy. Expert Opinion on Drug Metabolism & Toxicology. 5(3), 243-257.

Chua, W., Peters, M., Loneragan, R., Clarke, S. (2009), Cetuximab-associated pulmonary toxicity. Clinical colorectal cancer. 8(2), 118-120.

Matic, M., Nakhel, S., Lehnert, A., Polly, P., Clarke, S., Robertson, G. (2009), A novel approach to investigate the subcellular distribution of nuclear receptors in vivo. Nuclear Receptor Signaling. 7(0), e004.

Sobrero, A., Ackland, S., Clarke, S., Perez-Carrion, R., Chiara, S., Gapski, J., Mainwaring, P., Langer, B., Young, S. (2009), Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer. Oncology. 77(2), 113-119.

Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S. (2009), Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC cancer. 9(1), 130.

Sharma, R., Cunningham, D., Smith, P., Robertson, G., Dent, O., Clarke, S. (2009), Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients--analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO. BMC Cancer. 9, 153.
  1   2   3


Publications for Stephen Clarke iconStephen Jaros Stephen Jaros Southern University sjaros3@cox net Abstract

Publications for Stephen Clarke icon1 1The publications listed below form a part of this specification to the extent referenced. The publications are referred to in the text by the basic

Publications for Stephen Clarke iconOther Books by Stephen Bowman

Publications for Stephen Clarke iconApc annual Report 2006-2007 apc publications Category A. Apc funded Publications

Publications for Stephen Clarke iconThe Power That Preserves Stephen R. Donaldson

Publications for Stephen Clarke iconStephen (Steve) Brandt, M. D. Lab

Publications for Stephen Clarke iconTarmo A. Raadik, Peter S. Fairbrother and Stephen J. Smith

Publications for Stephen Clarke iconAnthropology of religion : a handbook / edited by Stephen D. Glazier

Publications for Stephen Clarke icon3. alec ident: interview with author stephen kelman

Publications for Stephen Clarke iconPublications Refereed Publications

Разместите кнопку на своём сайте:

База данных защищена авторским правом © 2014
обратиться к администрации
Главная страница